A Study of Tagmokitug in Combination With Other Treatments in Participants With Advanced or Metastatic Solid Tumors
Study sponsor: Coherus Oncology, Inc. · CHRS
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2028-08Estimated
Enrollment · participants12Estimated
Source updated2026-11-18Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.